Overexpression of RORα or treatment with SR1078, the RORα activator, reduced aerobic glycolysis, down-regulated biosynthetic pathways, reduced PDK2 expression, inhibited the phosphorylation of pyruvate dehydrogenase, and subsequently shifted pyruvate to complete oxidation in hepatoma cells. Here, PDK2 is linked to hepatocellular carcinoma.